Monte Rosa Therapeutics, Inc. (GLUE)

Monte Rosa Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 6, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Cap	1,410	427	283	375	950	-
Market Cap Growth	246.10%	50.68%	-24.53%	-60.50%	-	-
Enterprise Value	1,059	97.43	96.92	159.53	604.19	0
Last Close Price	17.80	6.94	5.65	7.61	20.42	-
PE Ratio	70.52	-7.08	-2.15	-3.31	-6.90	-
PS Ratio	7.77	5.64	-	-	-	-
PB Ratio	4.47	1.91	1.58	1.38	2.73	-
P/TBV Ratio	5.97	2.30	1.62	1.32	1.47	-
P/FCF Ratio	9.72	11.23	-4.51	-3.56	-13.75	-
P/OCF Ratio	9.45	10.16	-6.47	-4.06	-16.01	-
EV/Sales Ratio	5.83	1.29	-	-	-	-
EV/EBITDA Ratio	62.86	-1.33	-0.71	-1.47	-8.54	-
EV/EBIT Ratio	124.38	-1.20	-0.68	-1.42	-8.29	-
EV/FCF Ratio	7.30	2.56	-1.54	-1.51	-8.74	-
Debt / Equity Ratio	0.16	0.19	0.26	0.17	0	0
Debt / EBITDA Ratio	2.38	-0.58	-0.34	-0.43	-	-
Debt / FCF Ratio	0.28	1.12	-0.73	-0.45	-	-
Net Debt / Equity Ratio	-1.43	-1.48	-1.04	-0.79	-1.00	0.86
Net Debt / EBITDA Ratio	-20.85	4.51	1.36	1.99	4.89	1.52
Net Debt / FCF Ratio	-2.42	-8.67	2.97	2.05	5.01	1.58
Asset Turnover	0.40	0.20	0	0	0	0
Quick Ratio	6.45	2.37	5.00	10.58	20.80	1.42
Current Ratio	6.54	2.40	5.07	10.79	20.96	1.49
Return on Equity (ROE)	8.94%	-36.15%	-60.07%	-35.06%	-40.35%	-277.72%
Return on Assets (ROA)	1.81%	-22.65%	-44.47%	-31.71%	-35.06%	-92.64%
Return on Invested Capital (ROIC)	24.33%	-220.77%	-279.76%	-370.04%	-8554.23%	15604.46%
Return on Capital Employed (ROCE)	2.50%	-30.10%	-49.94%	-33.72%	-39.42%	-208.21%
Earnings Yield	1.49%	-14.12%	-46.55%	-30.22%	-14.50%	-
FCF Yield	10.29%	8.90%	-22.18%	-28.07%	-7.27%	-
Buyback Yield / Dilution	-0.29%	-23.32%	-9.75%	-5.55%	-25.04%	-

Updated Nov 6, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q